Clinical Experience: Practical Management of Five Patients With Cutaneous T-Cell Lymphoma (CTCL)-Related Symptoms
To access this article, please choose from the options below
This supplement was supported by an unrestricted educational grant from Zeneus Pharma Ltd.
Prof Foss is a member of the speakers’ bureau for Ligand Pharmaceuticals. Prof Bagot has served as a consultant to Zeneus. Prof Dummer has participated in scientific symposia and advisory boards sponsored by Zeneus and Ligand Pharmaceuticals.
PII: S0093-7754(05)00514-2
doi:10.1053/j.seminoncol.2005.12.020
© 2006 Elsevier Inc. All rights reserved.
